|
|
|
|
|
| |
Bayer Tops Third-Quarter Estimate |
|
| |
8:26 AM EST November 09 2005 |
|
|
| |
Bayer, pharmaceutical company, reported that Q3 net income soared to 493 million euros from 52 million euros in the same period last year on 19.1% revenue growth euros, topping analysts’ forecasts of 291 million euros. The company raised earnings expectations for the second time this year in view of its net income growth and with EBIT before special items doubling to 691 million euros. If not for special gains of 179 million euros, mostly from pension plan changes, Bayer stated that its healthcare and material science divisions had the biggest earnings contribution. |
|
|
| |
|
|
|
|
